Literature DB >> 22718532

Asparaginyl endopeptidase cleaves TDP-43 in brain.

Jeremy H Herskowitz1, Yair M Gozal, Duc M Duong, Eric B Dammer, Marla Gearing, Keqiang Ye, James J Lah, Junmin Peng, Allan I Levey, Nicholas T Seyfried.   

Abstract

TAR DNA-binding protein 43 (TDP-43) is a nuclear protein involved in RNA splicing and a major protein component in ubiquitin-positive, tau-negative inclusions of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Under disease conditions, TDP-43 redistributes to the cytoplasm where it can be phosphorylated, ubiquitinated, and proteolytically cleaved. Enzymes responsible for TDP-43 proteolytic processing in brain remain largely unreported. Using a MS approach, we identified two truncated TDP-43 peptides, terminating C-terminal to asparagines 291 (N291) and 306 (N306). The only documented mammalian enzyme capable of cleaving C-terminal to asparagine is asparaginyl endopeptidase (AEP). TDP-43-immunoreactive fragments (~35 and 32 kDa) predicted to be generated by AEP cleavage at N291 and N306 were observed by Western blot analyses of postmortem frontotemporal lobar degeneration brain tissue and cultured human cells over-expressing TDP-43. Studies in vitro determined that AEP can directly cleave TDP-43 at seven sites, including N291 and N306. Western blots of brain homogenates isolated from AEP-null mice and wild-type littermate controls revealed that TDP-43 proteolytic fragments were substantially reduced in the absence of AEP in vivo. Taken together, we conclude that TDP-43 is cleaved by AEP in brain. Moreover, these data highlight the utility of combining proteomic strategies in vitro and in vivo to provide insight into TDP-43 biology that will fuel the design of more detailed models of disease pathogenesis.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718532      PMCID: PMC3787696          DOI: 10.1002/pmic.201200006

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  39 in total

Review 1.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

Review 2.  Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

Authors: 
Journal:  Neurobiol Aging       Date:  1997 Jul-Aug       Impact factor: 4.673

3.  Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43.

Authors:  Takashi Nonaka; Fuyuki Kametani; Tetsuaki Arai; Haruhiko Akiyama; Masato Hasegawa
Journal:  Hum Mol Genet       Date:  2009-06-10       Impact factor: 6.150

4.  Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity.

Authors:  Yong-Jie Zhang; Ya-Fei Xu; Casey Cook; Tania F Gendron; Paul Roettges; Christopher D Link; Wen-Lang Lin; Jimei Tong; Monica Castanedes-Casey; Peter Ash; Jennifer Gass; Vijayaraghavan Rangachari; Emanuele Buratti; Francisco Baralle; Todd E Golde; Dennis W Dickson; Leonard Petrucelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

5.  An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation.

Authors:  B Manoury; E W Hewitt; N Morrice; P M Dando; A J Barrett; C Watts
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

6.  Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations.

Authors:  Ian R A Mackenzie; Manuela Neumann; Eileen H Bigio; Nigel J Cairns; Irina Alafuzoff; Jillian Kril; Gabor G Kovacs; Bernardino Ghetti; Glenda Halliday; Ida E Holm; Paul G Ince; Wouter Kamphorst; Tamas Revesz; Annemieke J M Rozemuller; Samir Kumar-Singh; Haruhiko Akiyama; Atik Baborie; Salvatore Spina; Dennis W Dickson; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2008-11-18       Impact factor: 17.088

7.  Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains.

Authors:  Nicholas T Seyfried; Yair M Gozal; Eric B Dammer; Qiangwei Xia; Duc M Duong; Dongmei Cheng; James J Lah; Allan I Levey; Junmin Peng
Journal:  Mol Cell Proteomics       Date:  2010-01-04       Impact factor: 5.911

8.  Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease.

Authors:  Yair M Gozal; Duc M Duong; Marla Gearing; Dongmei Cheng; John J Hanfelt; Christopher Funderburk; Junmin Peng; James J Lah; Allan I Levey
Journal:  J Proteome Res       Date:  2009-11       Impact factor: 4.466

9.  Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies.

Authors:  Lionel M Igaz; Linda K Kwong; Alice Chen-Plotkin; Matthew J Winton; Travis L Unger; Yan Xu; Manuela Neumann; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

10.  Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin.

Authors:  Dorothee Dormann; Anja Capell; Aaron M Carlson; Sunita S Shankaran; Ramona Rodde; Manuela Neumann; Elisabeth Kremmer; Takashi Matsuwaki; Keitaro Yamanouchi; Masugi Nishihara; Christian Haass
Journal:  J Neurochem       Date:  2009-06-09       Impact factor: 5.372

View more
  29 in total

1.  Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.

Authors:  Hualong Wang; Xia Liu; Shengdi Chen; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-10       Impact factor: 11.205

2.  Asparagine endopeptidase cleaves tau and promotes neurodegeneration.

Authors:  Hanna Rosenmann
Journal:  Nat Med       Date:  2014-11       Impact factor: 53.440

3.  Massive accumulation of luminal protease-deficient axonal lysosomes at Alzheimer's disease amyloid plaques.

Authors:  Swetha Gowrishankar; Peng Yuan; Yumei Wu; Matthew Schrag; Summer Paradise; Jaime Grutzendler; Pietro De Camilli; Shawn M Ferguson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

4.  An insoluble frontotemporal lobar degeneration-associated TDP-43 C-terminal fragment causes neurodegeneration and hippocampus pathology in transgenic mice.

Authors:  Adam K Walker; Kalyan Tripathy; Clark R Restrepo; Guanghui Ge; Yan Xu; Linda K Kwong; John Q Trojanowski; Virginia M-Y Lee
Journal:  Hum Mol Genet       Date:  2015-10-16       Impact factor: 6.150

5.  Lysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106B.

Authors:  Massimiliano Stagi; Zoe A Klein; Travis J Gould; Joerg Bewersdorf; Stephen M Strittmatter
Journal:  Mol Cell Neurosci       Date:  2014-07-24       Impact factor: 4.314

6.  BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT.

Authors:  Zhi-Hao Wang; Wanqiang Wu; Seong Su Kang; Xia Liu; Zhiping Wu; Junmin Peng; Shan Ping Yu; Fredric P Manfredsson; Ivette M Sandoval; Xuebo Liu; Jian-Zhi Wang; Keqiang Ye
Journal:  JCI Insight       Date:  2018-08-23

7.  Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.

Authors:  Chadwick M Hales; Eric B Dammer; Qiudong Deng; Duc M Duong; Marla Gearing; Juan C Troncoso; Madhav Thambisetty; James J Lah; Joshua M Shulman; Allan I Levey; Nicholas T Seyfried
Journal:  Proteomics       Date:  2016-12       Impact factor: 3.984

Review 8.  Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases.

Authors:  Zhentao Zhang; Manling Xie; Keqiang Ye
Journal:  Expert Opin Ther Targets       Date:  2016-05-13       Impact factor: 6.902

9.  Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease.

Authors:  Zhentao Zhang; Seong Su Kang; Xia Liu; Eun Hee Ahn; Zhaohui Zhang; Li He; P Michael Iuvone; Duc M Duong; Nicholas T Seyfried; Matthew J Benskey; Fredric P Manfredsson; Lingjing Jin; Yi E Sun; Jian-Zhi Wang; Keqiang Ye
Journal:  Nat Struct Mol Biol       Date:  2017-07-03       Impact factor: 15.369

10.  Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance.

Authors:  Manuela Neumann; Edward B Lee; Ian R Mackenzie
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.